Details for Patent: 5,238,924
Summary for Patent: 5,238,924
| Title: | Treatment of renal diseases with ace inhibitors |
| Abstract: | There is disclosed the use of angiotensin converting enzyme (ACE) inhibitors to alter the progression of renal diseases by affecting intraglomerular hemodynamics and proteinuria; i.e., affecting blood pressure within the functioning, filtering tissue of the kidney and the quantity of albumin in the urine. |
| Inventor(s): | Ronald D. Smith |
| Assignee: | Brigham and Womens Hospital Inc , Merck Sharp and Dohme LLC |
| Application Number: | US07/721,790 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,238,924
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,238,924
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 4178185 | ⤷ Start Trial | |||
| Australia | 569789 | ⤷ Start Trial | |||
| Denmark | 175190 | ⤷ Start Trial | |||
| Denmark | 197985 | ⤷ Start Trial | |||
| European Patent Office | 0160307 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
